Year |
Citation |
Score |
2018 |
Lander SS, Khan U, Lewandowski N, Chakraborty D, Provenzano FA, Mingote S, Chornyy S, Frigerio F, Maechler P, Kaphzan H, Small SA, Rayport S, Gaisler-Salomon I. Glutamate Dehydrogenase-Deficient Mice Display Schizophrenia-Like Behavioral Abnormalities and CA1-Specific Hippocampal Dysfunction. Schizophrenia Bulletin. PMID 29471549 DOI: 10.1093/Schbul/Sby011 |
0.566 |
|
2017 |
Lander SS, Chakraborti D, Donner R, Provenzano F, Lewandowski N, Mingote SM, Maechler P, Rayport S, Small SA, Kaphzan H, Gaisler-Salomon I. 216. Glutamate Dehydrogenase-Deficient Mice: A Novel Mouse Model of Schizophrenia-Like Phenotypes Schizophrenia Bulletin. 43: S109-S110. DOI: 10.1093/Schbul/Sbx021.294 |
0.555 |
|
2013 |
Lewandowski NM, Bordelon Y, Brickman AM, Angulo S, Khan U, Muraskin J, Griffith EY, Wasserman P, Menalled L, Vonsattel JP, Marder K, Small SA, Moreno H. Regional vulnerability in Huntington's disease: fMRI-guided molecular analysis in patients and a mouse model of disease. Neurobiology of Disease. 52: 84-93. PMID 23220414 DOI: 10.1016/J.Nbd.2012.11.014 |
0.559 |
|
2013 |
Lewandowski NM, Bordelon Y, Brickman AM, Angulo S, Khan U, Muraskin J, Griffith EY, Wasserman P, Menalled L, Vonsattel JP, Marder K, Small SA, Moreno H. Corrigendum to "Regional vulnerability in Huntington's disease: FMRI-guided molecular analysis in patients and a mouse model of disease" [Neurobiol Dis 52 (2013) 84-93] Neurobiology of Disease. 54: 115. DOI: 10.1016/J.Nbd.2013.03.001 |
0.469 |
|
2010 |
Lewandowski NM, Ju S, Verbitsky M, Ross B, Geddie ML, Rockenstein E, Adame A, Muhammad A, Vonsattel JP, Ringe D, Cote L, Lindquist S, Masliah E, Petsko GA, Marder K, et al. Polyamine pathway contributes to the pathogenesis of Parkinson disease. Proceedings of the National Academy of Sciences of the United States of America. 107: 16970-5. PMID 20837543 DOI: 10.1073/Pnas.1011751107 |
0.48 |
|
2009 |
Schobel SA, Lewandowski NM, Corcoran CM, Moore H, Brown T, Malaspina D, Small SA. Differential targeting of the CA1 subfield of the hippocampal formation by schizophrenia and related psychotic disorders. Archives of General Psychiatry. 66: 938-46. PMID 19736350 DOI: 10.1001/Archgenpsychiatry.2009.115 |
0.564 |
|
2009 |
Gaisler-Salomon I, Miller GM, Chuhma N, Lee S, Zhang H, Ghoddoussi F, Lewandowski N, Fairhurst S, Wang Y, Conjard-Duplany A, Masson J, Balsam P, Hen R, Arancio O, Galloway MP, et al. Glutaminase-deficient mice display hippocampal hypoactivity, insensitivity to pro-psychotic drugs and potentiated latent inhibition: relevance to schizophrenia. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2305-22. PMID 19516252 DOI: 10.1038/Npp.2009.58 |
0.591 |
|
2008 |
Chen YJ, Johnson MA, Lieberman MD, Goodchild RE, Schobel S, Lewandowski N, Rosoklija G, Liu RC, Gingrich JA, Small S, Moore H, Dwork AJ, Talmage DA, Role LW. Type III neuregulin-1 is required for normal sensorimotor gating, memory-related behaviors, and corticostriatal circuit components. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 28: 6872-83. PMID 18596162 DOI: 10.1523/Jneurosci.1815-08.2008 |
0.527 |
|
2005 |
Lewandowski NM, Small SA. Brain microarray: finding needles in molecular haystacks. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 25: 10341-6. PMID 16280569 DOI: 10.1523/Jneurosci.4006-05.2005 |
0.472 |
|
Show low-probability matches. |